PRESS RELEASES
<< Back
Xcel Brands, Inc. Announces Third Quarter 2022 Results
- Company continues to expand it’s linear T.V. and digital livestreaming platforms adding
Ken Downing andChristian Siriano to its on-air talent roster. - Revenues of
$4.5 million for the quarter endedSeptember 30, 2022 ;$21.7 million on a year-to-date basis - Third quarter net loss of
$4.0 million , or$(0.21) per share, on a GAAP basis; net loss of$3.3 million , or$(0.17) per share, on a non-GAAP basis - Nine month 2022 net income of
$2.0 million , or$0.10 per share, on a GAAP basis; net loss of$8.8 million , or$(0.45) per share, on a non-GAAP basis
Third Quarter 2022 Financial Results
Total revenue was
Net loss attributable to
Nine Month 2022 Financial Results
Total revenue was
Net income attributable to
Balance Sheet
The Company's balance sheet at
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details at
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
216-464-6400
andrew@smberger.com
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
For the Three Months Ended |
For the Nine Months Ended |
|||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Revenues | ||||||||||||||||
Net licensing revenue | $ | 2,166 | $ | 6,854 | $ | 13,302 | $ | 17,385 | ||||||||
Net sales | 2,335 | 4,407 | 8,413 | 12,449 | ||||||||||||
Net revenue | 4,501 | 11,261 | 21,715 | 29,834 | ||||||||||||
Cost of goods sold | 1,465 | 2,865 | 5,715 | 7,763 | ||||||||||||
Gross profit | 3,036 | 8,396 | 16,000 | 22,071 | ||||||||||||
Operating costs and expenses | ||||||||||||||||
Salaries, benefits and employment taxes | 3,301 | 4,185 | 13,390 | 12,286 | ||||||||||||
Other selling, general and administrative expenses | 3,567 | 3,463 | 10,762 | 9,591 | ||||||||||||
Stock-based compensation | 51 | 163 | 568 | 754 | ||||||||||||
Depreciation and amortization | 1,815 | 1,891 | 5,447 | 4,949 | ||||||||||||
Total operating costs and expenses | 8,734 | 9,702 | 30,167 | 27,580 | ||||||||||||
Other (expense) income | ||||||||||||||||
Loss from equity method investment | (277 | ) | (277 | ) | ||||||||||||
Gain on sale of majority interest in Isaac Mizrahi brand | - | - | 20,608 | - | ||||||||||||
Total other (expense) income | (277 | ) | 20,331 | |||||||||||||
Operating (loss) income | (5,975 | ) | (1,306 | ) | 6,164 | (5,509) | ||||||||||
Interest and finance (income) expense | ||||||||||||||||
Interest expense - term loan debt | 0 | 565 | 1,032 | 1,363 | ||||||||||||
Other interest and finance charges (income), net | (6 | ) | 23 | 149 | 127 | |||||||||||
Loss on extinguishment of debt | 0 | 0 | 2,324 | 821 | ||||||||||||
Total interest and finance (income) expense | (6 | ) | 588 | 3,505 | 2,311 | |||||||||||
Income (loss) before income taxes | (5,969 | ) | (1,894 | ) | 2,659 | (7,820 | ) | |||||||||
Income tax (benefit) provision | (1,539 | ) | (535 | ) | 1,639 | (2,019 | ) | |||||||||
Net income (loss) | (4,430 | ) | (1,359 | ) | 1,020 | (5,801 | ) | |||||||||
Net loss attributable to noncontrolling interest | (388 | ) | (223 | ) | (941 | ) | (560 | ) | ||||||||
Net (loss) income attributable to |
$ | (4,042 | ) | $ | (1,136 | ) | $ | 1,961 | $ | (5,241 | ) | |||||
Loss per share attributed to |
||||||||||||||||
Basic net (loss) income per share | $ | (0.21 | ) | $ | (0.06 | ) | $ | 0.10 | $ | (0.27 | ) | |||||
Diluted net (loss) income per share | $ | (0.21 | ) | $ | (0.06 | ) | $ | 0.10 | $ | (0.27 | ) | |||||
Weighted average number of common shares outstanding: | ||||||||||||||||
Basic weighted average common shares outstanding | 19,624,860 | 19,541,774 | 19,624,604 | 19,418,469 | ||||||||||||
Diluted weighted average common shares outstanding | 19,624,860 | 19,541,774 | 19,752,339 | 19,418,469 | ||||||||||||
Unaudited Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
(Unaudited) | |||||||||
Assets | |||||||||
Current Assets: | |||||||||
Cash and cash equivalents | $ | 8,407 | $ | 4,483 | |||||
Accounts receivable, net | 6,720 | 7,640 | |||||||
Inventory | 3,884 | 3,375 | |||||||
Prepaid expenses and other current assets | 1,752 | 1,681 | |||||||
Total current assets | 20,763 | 17,179 | |||||||
Non-Current Assets: | |||||||||
Property and equipment, net | 1,948 | 2,549 | |||||||
Operating lease right-of-use assets | 5,650 | 6,314 | |||||||
Trademarks and other intangibles, net | 49,200 | 98,304 | |||||||
Equity method investment | 19,520 | - | |||||||
Restricted cash | - | 739 | |||||||
Deferred tax assets, net | - | 141 | |||||||
Other assets | 146 | 555 | |||||||
Total non-current assets | 76,464 | 108,602 | |||||||
Total Assets | $ | 97,227 | $ | 125,781 | |||||
Liabilities and Equity | |||||||||
Current Liabilities: | |||||||||
Accounts payable, accrued expenses and other current liabilities | $ | 3,959 | $ | 6,169 | |||||
Accrued income taxes payable | 1,326 | 64 | |||||||
Accrued payroll | 228 | 577 | |||||||
Current portion of contingent obligations | 2,478 | - | |||||||
Current portion of operating lease obligations | 1,331 | 1,207 | |||||||
Current portion of long-term debt | - | 2,500 | |||||||
Total current liabilities | 9,322 | 10,517 | |||||||
Long-Term Liabilities: | |||||||||
Long-term portion of operating lease obligations | 6,157 | 7,252 | |||||||
Long-term debt, less current portion | - | 25,531 | |||||||
Contingent obligations, net of short term portion | 5,061 | 7,539 | |||||||
Deferred tax liabilities, net | 223 | - | |||||||
Total long-term liabilities | 11,441 | 40,322 | |||||||
Total Liabilities | 20,763 | 50,839 | |||||||
Commitments and Contingencies | |||||||||
Equity: | |||||||||
Preferred stock, |
- | - | |||||||
Common stock, issued and outstanding at |
20 | 20 | |||||||
Paid-in capital | 103,541 | 103,039 | |||||||
Accumulated deficit | (26,818 | ) | (28,779 | ) | |||||
76,743 | 74,280 | ||||||||
Noncontrolling interest | (279 | ) | 662 | ||||||
Total Stockholders' equity | 76,464 | 74,942 | |||||||
Total Liabilities and Stockholders' Equity | $ | 97,227 | $ | 125,781 | |||||
Unaudited Condensed Consolidated Statements of Cash Flows
(in thousands)
For the Nine Months Ended |
|||||||||
2022 |
2021 |
||||||||
Cash flows from operating activities | |||||||||
Net income (loss) | $ | 1,020 | $ | (5,801 | ) | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||||
Depreciation and amortization expense | 5,447 | 4,949 | |||||||
Amortization of deferred finance costs included in interest expense | 156 | 211 | |||||||
Stock-based compensation | 568 | 754 | |||||||
Allowance for doubtful accounts | 173 | 132 | |||||||
Loss on extinguishment of debt | 2,324 | 821 | |||||||
Income tax provision (benefit) | 363 | (2,019 | ) | ||||||
Undistributed proportional share of net loss of equity investment | 277 | ||||||||
Gain on sale of majority gain on sale of majority interest in Isaac Mizrahi brand | (20,608 | ) | - | ||||||
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | 747 | (2,192 | ) | ||||||
Inventory | (509 | ) | (2,214 | ) | |||||
Prepaid expenses and other current and non-current assets | 235 | (620 | ) | ||||||
Accounts payable, accrued expenses and other current liabilities | (796 | ) | 572 | ||||||
Lease related assets and liabilities | (202 | ) | |||||||
Other liabilities | (224 | ) | (122 | ) | |||||
Net cash used in by operating activities | (11,029 | ) | (5,529 | ) | |||||
Cash flows from investing activities | |||||||||
Net proceeds from sale of majority interest in Isaac Mizrahi brand | 45,408 | ||||||||
Cash consideration for acquisition of Lori Goldstein assets | - | (3,661 | ) | ||||||
Purchase of other intangible assets | - | (39 | ) | ||||||
Purchase of property and equipment | (241 | ) | (1,049 | ) | |||||
Net cash used in investing activities | 45,167 | (4,749 | ) | ||||||
Cash flows from financing activities | |||||||||
Proceeds from exercise of stock options | - | 5 | |||||||
Shares repurchased including vested restricted stock in exchange for withholding taxes | (442 | ) | - | ||||||
Cash contribution from non-controlling interest | - | 1,000 | |||||||
Proceeds from revolving loan debt | - | 2,498 | |||||||
Proceeds from long-term debt | - | 25,000 | |||||||
Payment of deferred finance costs | - | (1,204 | ) | ||||||
Payment of long-term debt | (29,000 | ) | (18,000 | ) | |||||
Payment of prepayment, and other fees associated with extinguishment of long-term debt | (1,511 | ) | (367 | ) | |||||
Net cash (used) provided in financing activities | (30,953 | ) | 8,932 | ||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | 3,185 | (1,346 | ) | ||||||
Cash, cash equivalents, and restricted cash at beginning of period | 5,222 | 6,066 | |||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 8,407 | $ | 4,720 | |||||
Reconciliation to amounts on consolidated balance sheets: | |||||||||
Cash and cash equivalents | 8,407 | $ | 3,981 | ||||||
Restricted cash | - | 739 | |||||||
Total cash, cash equivalents, and restricted cash | $ | 8,407 | $ | 4,720 | |||||
Supplemental disclosure of non-cash activities: | |||||||||
Operating lease right-of-use asset | - | (722 | ) | ||||||
Operating lease obligation | - | (722 | ) | ||||||
Contingent obligation related to acquisition of Lori Goldstein assets at fair value | - | 6,639 | |||||||
Liability for equity-based bonuses | $ | (283 | ) | $ | 140 | ||||
Supplemental disclosure of cash flow information: | |||||||||
Cash paid during the period for interest | $ | 1,032 | $ | 1,346 | |||||
Cash paid during the period for income taxes | $ | - | $ | 18 | |||||
Non-GAAP net income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net income (loss) attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results. Adjusted EBITDA is the measure used to calculate compliance with the EBITDA covenant under our term loan agreement.
Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do. In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
($ in thousands) | Three Months Ended |
Nine Months Ended |
|||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Net (loss) income attributable to |
$ | (4,042 | ) | (1,136 | ) | $ | 1,961 | (5,241 | ) | ||||||
Amortization of trademarks | 1,520 | 1,519 | 4,559 | 3,915 | |||||||||||
Stock-based compensation | 51 | 163 | 568 | 754 | |||||||||||
Loss on extinguishment of debt | - | - | 2,324 | 821 | |||||||||||
Proportional share of amortization of equity method investment | 742 | - | 742 | - | |||||||||||
Certain adjustments to provision for doubtful accounts | - | - | - | 132 | |||||||||||
Gain on the sale of assets | - | - | (20,608 | ) | - | ||||||||||
Income tax (benefit) provison | (1,539 | ) | (535 | ) | 1,639 | (2,019 | ) | ||||||||
Non-GAAP net (loss) income | $ | (3,268 | ) | $ | 11 | $ | (8,815 | ) | $ | (1,638 | ) | ||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Diluted earnings (loss) per share | $ | (0.21 | ) | $ | (0.06 | ) | $ | 0.10 | $ | (0.27 | ) | ||||
Amortization of trademarks | 0.08 | 0.08 | 0.23 | 0.20 | |||||||||||
Stock-based compensation | 0.00 | 0.01 | 0.03 | 0.04 | |||||||||||
Loss on extinguishment of debt | - | - | 0.12 | 0.04 | |||||||||||
Proportional share of amortization of equity method investment | 0.04 | - | 0.04 | - | |||||||||||
Certain adjustments to provision for doubtful accounts | - | - | - | 0.01 | |||||||||||
Gain on the sale of assets | - | - | (1.05 | ) | - | ||||||||||
Income tax provison (benefit) | (0.08 | ) | (0.03 | ) | 0.08 | (0.10 | ) | ||||||||
Non-GAAP diluted EPS | $ | (0.17 | ) | $ | 0.00 | $ | (0.45 | ) | $ | (0.08 | ) | ||||
Non-GAAP weighted average diluted shares | 19,624,860 | 20,323,358 | 19,624,604 | 19,418,469 | |||||||||||
($ in thousands) | Three Months Ended |
Nine Months Ended |
|||||||||||||
2022 |
2021 |
2022 |
2021 | ||||||||||||
(Unaudited) |
(Unaudited) |
(Unaudited) |
(Unaudited) | ||||||||||||
Net income (loss) attributable to |
$ | (4,042 | ) | $ | (1,136 | ) | $ | 1,961 | $ | (5,241 | ) | ||||
Depreciation and amortization | 1,815 | 1,891 | 5,447 | 4,949 | |||||||||||
Proportional share of amortization of equity method investment | 742 | - | 742 | - | |||||||||||
Interest and finance expense | (6 | ) | 588 | 3,505 | 2,311 | ||||||||||
Income tax provision (benefit) | (1,539 | ) | (535 | ) | 1,639 | (2,019 | ) | ||||||||
State and local franchise taxes | 85 | 33 | 121 | 105 | |||||||||||
Stock-based compensation | 51 | 163 | 568 | 754 | |||||||||||
Certain adjustments to provision for doubtful accounts | - | - | - | 132 | |||||||||||
Gain on the sale of assets | - | - | (20,608 | ) | - | ||||||||||
Adjusted EBITDA | $ | (2,894 | ) | $ | 1,004 | $ | (6,625 | ) | $ | 991 | |||||
Source: Xcel Brands, Inc